MedAI Verdict

AI Radiology

Editorial illustration: a chest radiograph alongside a magnifying glass highlighting flagged regions in blue.

Aidoc vs Qure.ai

All comparisons
71/ 100

Aidoc

37/ 100

Qure.ai

Scores are legacy evidence and documentation scores, not product-performance ratings. How it is computed

Head CT hemorrhage triage is where Aidoc and Qure overlap, and Aidoc has the large independent study for it. A real-world study of Aidoc BriefCase across 101,944 head CTs at 17 facilities reported 82.2% sensitivity and 97.6% specificity, dropping to 45.5% for subacute bleeds, 54.8% for chronic ones and 74.8% for bleeds of 10 mm or less. Qure's qER was cleared as CT triage in June 2020 (K200921). Its independent evidence sits on the chest X-ray side, where qXR v3 reached 95.5% sensitivity at 48.7% specificity for TB in a 12-product evaluation, at a single threshold.

Aidoc's modules cover CT triage, quantification, cardiology and neurovascular care, listed on AWS Marketplace at $6 per scan per algorithm per hospital site on a 12-month private offer. That suits an emergency CT worklist and gives a national TB program no reason to start there. Qure reports a WHO endorsement from 2021 for TB screening on chest X-ray, and the sources show no FDA clearance for Qure's TB screening, so Qure drops out for a US hospital that needs a cleared TB tool.

Radiology · Reviewed November 1, 2026

On this page
Aidoc logo

Aidoc

by Aidoc · founded 2016

Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.

Qure.ai logo

Qure.ai

by Qure.ai

AI for chest X-ray (qXR), head CT (qER) and lung nodule CT, with TB screening. The homepage cites sites across 107 countries.

When to pick each one

Aidoc

  • Real-world ICH study: 101,944 head CTs, 17 facilities
  • $6 per scan per algorithm, AWS Marketplace private offer
  • 35 openFDA 510(k) records since 2018
Read the full Aidoc review

Qure.ai

  • Qure reports WHO endorsement for TB screening, 2021
  • Chest X-ray, head CT and lung nodule CT products
  • qXR-LN cleared for adult frontal chest radiographs
Read the full Qure.ai review

Score

Each row shows points earned of points available under the published rubric.

Aidoc

71of 100

Qure.ai

37of 100
Score by dimension for Aidoc and Qure.ai
DimensionAidocQure.aiDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.20 / 18.2+12.7
RCT / meta-analysis / systematic review7.8 / 7.80 / 7.8+7.8
Funding & adoption signal12 / 128.4 / 12+3.6
Pricing transparency2.5 / 52.5 / 50

Scroll horizontally to see every column.

How scores are computed

Pricing

Aidoc

TierMonthlyAnnualNotes
Clinical AI Starter (AWS Marketplace)Not statedNot statedPrivate offer only. No trial is stated.
EnterpriseNot statedNot statedNo public price on aidoc.com. Quoted per module.

Qure.ai

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Grant funding is not stated on Qure pages.

Evidence

Aidoc

FDA decisions

Show 30 more

Peer-reviewed

4 PubMed records name Aidoc.

Compliance and integrations

Documented from each vendor’s own pages.

SpecAidocQure.ai
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot statedNot stated
Founded2016Not stated
HQILIN

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.

See all radiology